Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 21Neoplasms 6Carcinoma, Hepatocellular 5Stomach Neoplasms 4Recurrence 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Cancer 4Uveal Melanoma 3Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Liver Neoplasms 3Colonic Neoplasms 3Rectal Neoplasms 2Ovarian Neoplasms 2Neoplasms by Site 2Neoplasm Metastasis 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Hodgkin Disease 2Hematologic Neoplasms 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Renal Cell 2Carcinoma, Basal Cell 2Brain Neoplasms 2

Interventions

HhAntag691 21Biopsy 11Imiquimod 10Aminolevulinic Acid 9sonidegib 8Photochemotherapy 8Nivolumab 81-phenyl-3,3-dimethyltriazene 7methyl 5-aminolevulinate 6cemiplimab 6Surgical Procedures, Operative 5Specimen Handling 5Radiotherapy 5Itraconazole 5pembrolizumab 4daromun 4Mohs Surgery 4Magnetic Resonance Spectroscopy 4Ipilimumab 4Curettage 4Tomography, Optical Coherence 3Standard of Care 3Niacinamide 3Microscopy, Confocal 3IPI-926 3CTLA-4 Antigen 33-ingenyl angelate 3tazarotene 2talimogene laherparepvec 2relatlimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Basal Cell × relatlimab × Clear all
NCT03521830 2026-04-29

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
57 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT06624475 2026-02-05

NEON

University of California, San Diego

Phase 2 Recruiting
30 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡